Par Pharmaceutical Companies, Inc. has named Terrance J. Coughlin chief operating officer. In this capacity, Coughlin will be responsible for Par's global manufacturing activities, research and development efforts and will be instrumental in the new product selection process.

Coughlin joins Par from Glenmark Generics, Inc. USA/Glenmark Generics Limited, where he most recently served as president and chief executive officer for more than six years. Prior to that position, he served as president, Glenmark Generics Inc. USA. During his tenure with Glenmark, which began in 2004, he had overall responsibility for the North American, Western European and Eastern European generics businesses, as well as the global active pharmaceutical ingredient (API) business and Glenmark's generics operations in India. Prior to Glenmark, he served as senior vice-president at Dr. Reddy's Laboratories, Inc., which he joined in 1995. At Reddy's, he progressed through a series of positions of increasing responsibility until he was eventually responsible for North American, European, and global key account bulk active ingredient operations.

Source: Par Pharmaceutical